To Investigate the Absorption, Metabolism, Excretion, Absolute Bioavailability, and Immunogenicity of GX-I7 in Healthy Volunteers

NCT04283695 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Leukopenia

Interventions

DRUG: GX-I7 or [14C] GX-I7

Sponsor

Seoul National University Hospital